Next Article in Journal
Bioprospecting Fluorescent Plant Growth Regulators from Arabidopsis to Vegetable Crops
Next Article in Special Issue
Immune Aging and Immunotherapy in Cancer
Previous Article in Journal
UV-Irradiation- and Inflammation-Induced Skin Barrier Dysfunction Is Associated with the Expression of Olfactory Receptor Genes in Human Keratinocytes
Previous Article in Special Issue
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review
 
 
Review
Peer-Review Record

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

Int. J. Mol. Sci. 2021, 22(6), 2800; https://doi.org/10.3390/ijms22062800
by Florus C. de Jong 1,†, Vera C. Rutten 1,†, Tahlita C. M. Zuiverloon 1 and Dan Theodorescu 2,3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2021, 22(6), 2800; https://doi.org/10.3390/ijms22062800
Submission received: 11 February 2021 / Revised: 25 February 2021 / Accepted: 2 March 2021 / Published: 10 March 2021

Round 1

Reviewer 1 Report

The work is interesting and deserves consideration but the manuscript lacks the "materials and methods" section. As a review, it is necessary to follow the PRISMA criteria as required by the journal itself (the manuscript should use the same structure as research articles, as reported in submission guidelines). Moreover, the reader can not easily understand if the work is a narrative review, systematic review or meta-analysis

Author Response

We addressed the review criteria by implementing PRISMA 2009 Flow Diagram and other issues.

Reviewer 2 Report

Aim of the manuscript was to describe challenges and opportunities of PD-1/PD-L1 inhibition in HR-NMIBC. Manuscript is interesting and it addresses a still debated topic in Literature. Quality of the manuscript and studies reported are good and review well performed. 

Author Response

We addressed the review criteria by implementing PRISMA 2009 Flow Diagram and other issues.

Round 2

Reviewer 1 Report

The authors improved the manuscript as requested

Back to TopTop